Does CAPIVASERTIB Cause Metastases to liver? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Metastases to liver have been filed in association with CAPIVASERTIB (TRUQAP). This represents 2.0% of all adverse event reports for CAPIVASERTIB.
33
Reports of Metastases to liver with CAPIVASERTIB
2.0%
of all CAPIVASERTIB reports
5
Deaths
9
Hospitalizations
How Dangerous Is Metastases to liver From CAPIVASERTIB?
Of the 33 reports, 5 (15.2%) resulted in death, 9 (27.3%) required hospitalization, and 4 (12.1%) were considered life-threatening.
Is Metastases to liver Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPIVASERTIB. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does CAPIVASERTIB Cause?
Diarrhoea (278)
Rash (253)
Death (228)
Hyperglycaemia (152)
Nausea (96)
Vomiting (81)
Blood glucose increased (70)
Fatigue (67)
Malignant neoplasm progression (62)
Disease progression (61)
What Other Drugs Cause Metastases to liver?
LETROZOLE (1,295)
FULVESTRANT (1,241)
CAPECITABINE (1,061)
EVEROLIMUS (1,020)
RIBOCICLIB (967)
PACLITAXEL (885)
OCTREOTIDE (774)
BEVACIZUMAB (707)
FLUOROURACIL (630)
TAMOXIFEN (595)
Which CAPIVASERTIB Alternatives Have Lower Metastases to liver Risk?
CAPIVASERTIB vs CAPLACIZUMAB
CAPIVASERTIB vs CAPLACIZUMAB-YHDP
CAPIVASERTIB vs CAPMATINIB
CAPIVASERTIB vs CAPREOMYCIN
CAPIVASERTIB vs CAPSAICIN